Martel, Guillaume http://orcid.org/0000-0002-1242-2601
Lenet, Tori
Wherrett, Christopher
Carrier, François-Martin
Monette, Leah
Workneh, Aklile
Brousseau, Karine
Ruel, Monique
Chassé, Michaël
Collin, Yves
Vandenbroucke-Menu, Franck
Hamel-Perreault, Élodie
Perreault, Michel-Antoine
Park, Jeieung
Lim, Shirley
Maltais, Véronique
Leung, Philemon
Gilbert, Richard W. D.
Segedi, Maja
Abou-Khalil, Jad
Bertens, Kimberly A.
Balaa, Fady K.
Ramsay, Tim
Fergusson, Dean A.
Article History
Received: 22 October 2022
Accepted: 12 December 2022
First Online: 18 January 2023
Declarations
:
: The protocol, informed consent forms, and all other study material have been approved by the Ottawa Health Science Network - Research Ethics Board (20180452-01H). Each participating hospital’s Research Ethics Board (REB) has also approved the trial protocol. Consent material is available in French and English. Each participating patient or their substitute decision maker will provide written informed consent prior to enrolling in the study. PRICE-2 will be conducted according to Good Clinical Practice and based on the principles of the second version of the Tri-Council Policy Statement.
: Not applicable.
: The authors declare that they have no competing interests.